The link between periodontal disease (PD) and rheumatoid arthritis (RA) has been hypothesized to lie in the anti-cyclic citrullinated protein antibody (ACPA) molecules present in seropositive RA. This review aimed to discuss how RA and specifically ACPA-positive RA link to PD, and appraise the epidemiological evidence on the relationship between ACPA-positive RA and PD. Articles were searched following the PRISMA guideline across the MEDLINE, Web of Science, Scopus and Cochrane Library databases. A total of 21 articles met the inclusion criteria of reporting the epidemiological data on the different ACPA status of the subjects with RA and PD (or periodontitis) parameters. A discrepancy is noted in the epidemiological evidence on the difference in the prevalence and severity of PD between ACPA-positive and ACPA-negative RA patients. Although the link between RA and PD is mostly discussed in terms of ACPA, reports on the different manifestations of PD between the two RA subsets remains inconclusive.

1. Young A, Koduri G. Extra-articular manifestations and complications of rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2007;21:907–27. doi:10.1016/j.berh.2007.05.007.
2. Jung GU, Han JY, Hwang KG, Park CJ, Stathopoulou PG, Fiorellini JP. Effects of conventional synthetic disease-modifying antirheumatic drugs on response to periodontal treatment in patients with rheumatoid arthritis. Biomed Res Int. 2018;2018:1465402. doi:10.1155/2018/1465402.
3. Chen HH, Huang N, Chen YM, et al. Association between a history of periodontitis and the risk of rheumatoid arthritis: a nationwide, population-based, case-control study. Ann Rheum Dis. 2013;72:1206–11. doi:10.1136/annrheumdis-2012-201593.
4. Schmickler J, Rupprecht A, Patschan S, et al. Cross-sectional evaluation of periodontal status and microbiologic and rheumatoid parameters in a large cohort of patients with rheumatoid arthritis. J Periodontol. 2017;88:368–79. doi:10.1902/jop.2016.160355.
5. Joseph R, Rajappan S, Nath SG, Paul BJ. Association between chronic periodontitis and rheumatoid arthritis: a hospital-based case-control study. Rheumatol Int. 2013;33:103–9. doi:10.1007/s00296-011-2284-1.
6. de Oliveira Ferreira R, de Brito Silva R, Magno MB, et al. Does periodontitis represent a risk factor for rheumatoid arthritis? A systematic review and meta-analysis. Ther Adv Musculoskelet Dis. 2019;11:1759720X19858514. doi:10.1177/1759720X19858514.
7. Suhaimi N, Kamaruzaman N, Taib HT, Wan Mohamad WM, Wan Ghazali WS. Assessment of periodontal status in patients with rheumatoid arthritis. J Int Dent Med Res. 2016;9:108–12.
8. Khantisopon N, Louthrenoo W, Kasitanon N, et al. Periodontal disease in Thai patients with rheumatoid arthritis. Int J Rheum Dis. 2014;17:511–8. doi:10.1111/1756-185X.12315.
9. Monsarrat P, Vergnes JN, Blaizot A, et al. Oral health status in outpatients with rheumatoid arthritis: the OSARA study. Oral Health Dent Manag. 2014;13:113–9.
10. Pischon N, Pischon T, Kröger J, et al. Association among rheumatoid arthritis, oral hygiene, and periodontitis. J Periodontol. 2008;79:979–86. doi:10.1902/jop.2008.070501.
11. Hashimoto H, Hashimoto S, Muto A, et al. Influence of plaque control on the relationship between rheumatoid arthritis and periodontal health status among Japanese rheumatoid arthritis patients. J Periodontol. 2018;89:1033–42. doi:10.1002/JPER.17-0575.
12. Fuggle NR, Smith TO, Kaul A, Sofat N. Hand to mouth: a systematic review and meta-analysis of the association between rheumatoid arthritis and periodontitis. Front Immunol. 2016;7:80. doi:10.3389/fimmu.2016.00080.
13. Kaur S, White S, Bartold PM. Periodontal disease and rheumatoid arthritis: a systematic review. J Dent Res. 2013;92:399–408. doi:10.1177/0022034513483142.
14. Araújo VM, Melo IM, Lima V. Relationship between periodontitis and rheumatoid arthritis: review of the literature. Mediators Inflamm. 2015;2015:259074. doi:10.1155/2015/259074.
15. Abrão AL, Santana CM, Bezerra AC, et al. What rheumatologists should know about orofacial manifestations of autoimmune rheumatic diseases. Rev Bras Reumatol Engl Ed. 2016;56:441–50. doi:10.1016/j.rbre.2016.02.006.
16. Li R, Tian C, Postlethwaite A, et al. Rheumatoid arthritis and periodontal disease: what are the similarities and differences? Int J Rheum Dis. 2018;20:1887–901. doi:10.1111/1756-185X.13240.
17. Lundberg K, Wegner N, Yucel-Lindberg T, Venables PJ. Periodontitis in RA—the citrullinated enolase connection. Nat Rev Rheumatol. 2010;6:727–30. doi:10.1038/nrrheum.2010.139.
18. Farquharson D, Butcher JP, Culshaw S. Periodontitis, Porphyromonas, and the pathogenesis of rheumatoid arthritis. Mucosal Immunol. 2012;5:112–20. doi:10.1038/mi.2011.66.
19. Aletaha D, Neogi T, Silman AJ, et al. 2010 rheumatoid arthritis classification criteria. Ann Rheum Dis. 2010;69:1892. doi:10.1136/ard.2010.138461.
20. Gomez EL, Gun SC, Somnath SD, et al. Prevalence of rheumatoid factor isotypes and anti-CCP antibodies in Malaysian RA patients. Int J Rheum Dis. 2011;14:12–7. doi:10.1111/j.1756-185X.2010.01573.x
21. Arkema EV, Goldstein BL, Robinson W, et al. Anti-citrullinated peptide autoantibodies, human leukocyte antigen shared epitope and risk of future rheumatoid arthritis: a nested case-control study. Arthritis Res Ther. 2013;15:R159. doi:10.1186/ar4342.
22. Vander Cruyssen B, Peene I, Cantaert T, et al. Anti-citrullinated protein/peptide antibodies (ACPA) in rheumatoid arthritis: specificity and relation with rheumatoid factor. Autoimmun Rev. 2005;4:468–74. doi:10.1016/j.autrev.2005.04.018.
23. Rosenstein ED, Kushner LJ, Kramer N. Rheumatoid arthritis and periodontal disease: a rheumatologist’s perspective. Curr Oral Health Rep. 2015;2:9–19. doi:10.1007/s40496-014-0038-3.
24. Koziel J, Mydel P, Potempa J. The link between periodontal disease and rheumatoid arthritis: an updated review. Curr Rheumatol Rep. 2014;16:408. doi:10.1007/s11926-014-0408-9.
25. Quirke AM, Lugli EB, Wegner N, et al. Immune response to autocitrullinated Porphyromonas gingivalis PAD. Ann Rheum Dis. 2014;73:263–9. doi:10.1136/annrheumdis-2012-202726.
26. Golub LM, Payne JB, Reinhardt RA, Nieman G. Can systemic diseases co-induce periodontitis? A “two-hit” model. J Dent Res. 2006;85:102–5. doi:10.1177/154405910608500201.
27. Hitchon CA, Chandad F, Ferucci ED, et al. Antibodies to Porphyromonas gingivalis and ACPA in RA. J Rheumatol. 2010;37:1105–12. doi:10.3899/jrheum.091323.
28. Hajishengallis G, Darveau RP, Curtis MA. The keystone-pathogen hypothesis. Nat Rev Microbiol. 2012;10:717–25. doi:10.1038/nrmicro2873.
29. Reichert S, Haffner M, Keyßer G, et al. Detection of oral bacterial DNA in synovial fluid. J Clin Periodontol. 2013;40:591–8. doi:10.1111/jcpe.12102.
30. Potempa J, Mydel P, Koziel J. Periodontitis in the pathogenesis of rheumatoid arthritis. Nat Rev Rheumatol. 2017;13:606–20. doi:10.1038/nrrheum.2017.132.
31. Konig MF, Abusleme L, Reinholdt J, et al. Periodontal infection links to autoimmunity in RA. Sci Transl Med. 2016;8:369ra176. doi:10.1126/scitranslmed.aaj1921.
32. Tricco AC, Lillie E, Zarin W, et al. PRISMA extension for scoping reviews (PRISMA-ScR). Ann Intern Med. 2018;169:467–73. doi:10.7326/M18-0850.
33. Armitage GC. Classification system for periodontal diseases. Ann Periodontol. 1999;4:1–6. doi:10.1902/annals.1999.4.1.1.
34. Armitage GC, American Academy of Periodontology. Diagnosis of periodontal diseases. J Periodontol. 2003;74:1237–47. doi:10.1902/jop.2003.74.8.1237.
35. Van der Velden U. Dutch periodontal screening index validation. J Clin Periodontol. 2009;36:1018–24. doi:10.1111/j.1600-051X.2009.01495.x.
36. Machtei EE, Christersson LA, Grossi SG, et al. Definition of “established periodontitis.” J Periodontol. 1992;63:206–14. doi:10.1902/jop.1992.63.3.206.
37. Page RC, Eke PI. Case definitions for periodontitis surveillance. J Periodontol. 2007;78(Suppl 7):1387–99. doi:10.1902/jop.2007.060264.
38. Tonetti MS, Claffey N. Definitions of periodontitis progression. J Clin Periodontol. 2005;32(Suppl 6):210–3. doi:10.1111/j.1600-051X.2005.00822.x.
39. Eke PI, Page RC, Wei L, et al. Update of case definitions for periodontitis. J Periodontol. 2012;83:1449–54. doi:10.1902/jop.2012.110664.
40. Tonetti MS, Greenwell H, Kornman KS. Staging and grading of periodontitis. J Periodontol. 2018;89(Suppl 1):S159–72. doi:10.1002/JPER.18-0006.
41. Arnett FC, Edworthy SM, Bloch DA, et al. 1987 revised RA classification criteria. Arthritis Rheum. 1988;31:315–24. doi:10.1002/art.1780310302.
42. Terao C, Asai K, Hashimoto M, et al. Periodontal disease and ACPA in Japanese population. J Autoimmun. 2015;59:85–90. doi:10.1016/j.jaut.2015.03.002.
43. Eriksson K, Nise L, Kats A, et al. Prevalence of periodontitis in RA patients. PLoS One. 2016;11:e0155956. doi:10.1371/journal.pone.0155956.
44. Eriksson K, Fei G, Lundmark A, et al. Oral microbiota in RA patients. J Clin Med. 2019;8:630. doi:10.3390/jcm8050630.
45. Potikuri D, Dannana KC, Kanchinadam S, et al. Periodontal disease in treatment-naïve RA patients. Ann Rheum Dis. 2012;71:1541–4. doi:10.1136/annrheumdis-2011-200380.
46. Mikuls TR, Payne JB, Yu F, et al. Periodontitis and Porphyromonas gingivalis in RA. Arthritis Rheumatol. 2014;66:1090–100. doi:10.1002/art.38348.
47. Gonzalez SM, Payne JB, Yu F, et al. Alveolar bone loss and ACPA. J Periodontol. 2015;86:222–31. doi:10.1902/jop.2014.140425.
48. Choi IA, Kim J, Kim YM, et al. Periodontitis in longstanding RA patients. Korean J Intern Med. 2016;31:977–86. doi:10.3904/kjim.2015.202.
49. Eriksson K, Nise L, Alfredsson L, et al. Smoking, seropositivity and periodontitis in RA. Ann Rheum Dis. 2018;77:1236–8. doi:10.1136/annrheumdis-2017-212091.
50. Zhao R, Gu C, Zhang Q, et al. Periodontal disease in Chinese RA patients. Oral Dis. 2019;25:2003–9. doi:10.1111/odi.13176.
51. González-Febles J, Rodríguez-Lozano B, Sánchez-Piedra C, et al. Periodontitis and ACPA association. Arthritis Res Ther. 2020;22:27. doi:10.1186/s13075-020-2121-6.
52. Nguyen VB, Nguyen TT, Huynh NC, et al. Periodontitis and RA in Vietnamese patients. Acta Odontol Scand. 2020;78:522–8. doi:10.1080/00016357.2020.1747635.
53. Reichert S, Schlumberger W, Dähnrich C, et al. Antibodies in periodontitis as RA risk factor. J Transl Med. 2015;13:283. doi:10.1186/s12967-015-0625-7.
54. Havemose-Poulsen A, Westergaard J, Stoltze K, et al. Periodontal and hematological characteristics in RA. J Periodontol. 2006;77:280–8. doi:10.1902/jop.2006.050051.
55. Mohamad WMW, Jia SK, Ghazali WSW, Taib H. Anti-CCP and periodontal status in RA. Pak J Med Sci. 2018;34:907–12. doi:10.12669/pjms.344.15007.
56. Rodríguez-Lozano B, González-Febles J, Garnier-Rodríguez JL, et al. Periodontitis severity and RA activity. Arthritis Res Ther. 2019;21:2.7. doi:10.1186/s13075-019-1808-z.
57. Renvert S, Berglund JS, Persson GR, Söderlin MK. RA and periodontal disease association. BMC Rheumatol. 2020;4:31. doi:10.1186/s41927-020-00129-4.
58. Svärd A, Renvert S, Persson RG, Söderlin M. Antibodies in serum and saliva in RA. Clin Exp Rheumatol. 2020;38:699–704.
59. Rahajoe PS, de Smit M, Schuurmans G, et al. IgA ACPA in periodontal exudate. J Clin Periodontol. 2020;47:552–60. doi:10.1111/jcpe.13277.
60. Dissick A, Redman RS, Jones M, et al. Periodontitis and RA association pilot study. J Periodontol. 2010;81:223–30. doi:10.1902/jop.2009.090309.
61. de Smit M, Westra J, Vissink A, et al. Periodontitis in established RA. Arthritis Res Ther. 2012;14:R222. doi:10.1186/ar4061.
62. Äyräväinen L, Leirisalo-Repo M, Kuuliala A, et al. Periodontitis in early and chronic RA. BMJ Open. 2017;7:e011916. doi:10.1136/bmjopen-2016-011916.
63. Abdelsalam SK, Hashim NT, Elsalamabi EM, Gismalla BG. Periodontal status in RA patients. BMC Res Notes. 2011;4:460. doi:10.1186/1756-0500-4-460.
64. Kobayashi T, Murasawa A, Komatsu Y, et al. Cytokines and periodontal profile in RA. J Periodontol. 2010;81:650–7. doi:10.1902/jop.2010.090688.
65. Mercado FB, Marshall RI, Klestov AC, Bartold PM. RA and periodontitis relationship. J Periodontol. 2001;72:779–87. doi:10.1902/jop.2001.72.6.779.
66. Stefanov L, Bolyarova-Konova T, Kolarov Z, et al. Anti-CCP and periodontitis severity. Rheumatol (Bulgaria). 2020;28:11–18.